tiprankstipranks
Trending News
More News >
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market

Acura Pharmaceuticals (ACUR) Ratios

Compare
83 Followers

Acura Pharmaceuticals Ratios

ACUR's free cash flow for Q4 2021 was $0.25. For the 2021 fiscal year, ACUR's free cash flow was decreased by $ and operating cash flow was $0.81. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
0.72 0.16 1.10--
Quick Ratio
0.72 0.16 1.10--
Cash Ratio
0.13 0.05 0.80--
Solvency Ratio
-1.16 -0.20 -0.50--
Operating Cash Flow Ratio
-1.44 -0.10 -0.58--
Short-Term Operating Cash Flow Coverage
-22.48 -0.12 0.00--
Net Current Asset Value
$ -310.00K$ -6.45M$ -6.13M--
Leverage Ratios
Debt-to-Assets Ratio
0.23 3.61 2.34--
Debt-to-Equity Ratio
1.12 -1.06 -1.27--
Debt-to-Capital Ratio
0.53 16.58 4.77--
Long-Term Debt-to-Capital Ratio
0.46 -0.02 4.77--
Financial Leverage Ratio
4.83 -0.29 -0.54--
Debt Service Coverage Ratio
-2.53 -0.16 -7.16--
Interest Coverage Ratio
-6.07 -1.68 -1.61--
Debt to Market Cap
5.55 0.92 0.98--
Interest Debt Per Share
<0.01 0.21 0.24--
Net Debt to EBITDA
-0.23 -9.25 -1.69--
Profitability Margins
Gross Profit Margin
94.24%99.95%99.94%--
EBIT Margin
-43.44%-21.23%-124.65%--
EBITDA Margin
-37.68%-17.73%-114.38%--
Operating Profit Margin
-77.67%-21.23%-27.29%--
Pretax Profit Margin
-56.24%-33.84%-142.04%--
Net Profit Margin
-56.24%-46.44%-148.66%--
Continuous Operations Profit Margin
-56.24%-33.84%-142.04%--
Net Income Per EBT
100.00%137.25%104.66%--
EBT Per EBIT
72.41%159.37%520.55%--
Return on Assets (ROA)
-102.21%-95.51%-154.18%--
Return on Equity (ROE)
30.77%28.14%83.32%--
Return on Capital Employed (ROCE)
-351.88%13.10%-48.72%--
Return on Invested Capital (ROIC)
-295.38%-275.23%-51.00%--
Return on Tangible Assets
-102.21%-99.70%-225.46%--
Earnings Yield
-4000.00%-24.43%-64.27%--
Efficiency Ratios
Receivables Turnover
9.89 5.69 13.70--
Payables Turnover
0.47 0.06 <0.01--
Inventory Turnover
0.00 0.00 0.00--
Fixed Asset Turnover
3.57 7.38 4.92--
Asset Turnover
1.82 2.06 1.04--
Working Capital Turnover Ratio
-0.48 -1.14 -6.11--
Cash Conversion Cycle
-741.77 -6.29K -57.45K--
Days of Sales Outstanding
36.90 64.11 26.65--
Days of Inventory Outstanding
0.00 0.00 0.00--
Days of Payables Outstanding
778.67 6.35K 57.48K--
Operating Cycle
36.90 64.11 26.65--
Cash Flow Ratios
Operating Cash Flow Per Share
-0.02 -0.02 -0.02--
Free Cash Flow Per Share
-0.02 -0.02 -0.02--
CapEx Per Share
0.00 0.00 0.00--
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00--
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00--
Capital Expenditure Coverage Ratio
0.00 0.00 0.00--
Operating Cash Flow Coverage Ratio
-3.71 -0.11 -0.10--
Operating Cash Flow to Sales Ratio
-0.47 -0.20 -0.23--
Free Cash Flow Yield
-2248.42%-10.59%-10.06%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.03 -4.09 -1.56--
Price-to-Sales (P/S) Ratio
0.02 1.90 2.31--
Price-to-Book (P/B) Ratio
0.12 -1.15 -1.30--
Price-to-Free Cash Flow (P/FCF) Ratio
-0.04 -9.44 -9.94--
Price-to-Operating Cash Flow Ratio
-0.03 -9.44 -9.94--
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.06 0.09--
Price-to-Fair Value
0.12 -1.15 -1.30--
Enterprise Value Multiple
-0.29 -19.97 -3.71--
Enterprise Value
168.00K 12.64M 11.28M--
EV to EBITDA
-0.29 -19.97 -3.71--
EV to Sales
0.11 3.54 4.25--
EV to Free Cash Flow
-0.23 -17.58 -18.26--
EV to Operating Cash Flow
-0.23 -17.58 -18.26--
Tangible Book Value Per Share
<0.01 -0.18 -0.21--
Shareholders’ Equity Per Share
<0.01 -0.18 -0.18--
Tax and Other Ratios
Effective Tax Rate
0.00 -0.37 -0.05--
Revenue Per Share
0.04 0.11 0.10--
Net Income Per Share
-0.02 -0.05 -0.15--
Tax Burden
1.00 1.37 1.05--
Interest Burden
1.29 1.59 1.14--
Research & Development to Revenue
0.98 0.50 0.57--
SG&A to Revenue
0.80 0.71 0.71--
Stock-Based Compensation to Revenue
0.04 0.01 0.04--
Income Quality
0.84 0.60 0.16--
Currency in USD